In the single-center, prospective study of intranasal dexmedetomidine vs oral midazolam by Kenneally et al (PMID: 36728557), the subgroup of patients with autism spectrum disorder had lower rates of treatment failure with IN dex (21.2% vs 66.7%).

Great presentation, Hannah Morley!

#EMPRx2025

"Your career expands not just by seeking opportunities, but by becoming the pharmacist that opportunities seek out"

@ketaminepharmer911.bsky.social #EMPRx2025

@ketaminepharmer911.bsky.social discusses how to be invaluable to your institution

#EMPRx2025

It's a good idea to get involved in your institution's MCI plans so that decisions aren't solely being made by people who don't work bedside

#EMPRx2025 #cyanocobalaminisnothydroxocobalamin

Medications to consider for MCIs

#EMPRx2025

For residents to truly understand a topic, it helps to teach in layers of micro learning.

For example, instead of diving into an entire topic discussion of RSI, you could start with a 10min discussion of preoxygenation.

#EMPRx2025

EM pharmacists have several transferable skills if you decide to add a second job or switch careers #EMPRx2025